|
1
|
Stringham JC, Southard JH, Hegge J,
Triemstra L, Fields BL and Belzer FO: Limitations of heart
preservation by cold storage. Transplantation. 53:287–294. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Frank A, Bonney M, Bonney S, et al:
Myocardial ischemia reperfusion injury: from basic science to
clinical bedside. Semin Cardiothorac Vasc Anesth. 16:123–132. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jang IS, Park MY, Shin IW, Sohn JT, Lee HK
and Chung YK: Ethyl pyruvate has anti-inflammatory and delayed
myocardial protective effects after regional ischemia/reperfusion
injury. Yonsei Med J. 51:838–844. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Guo J, Zhang K, Ji Y, et al: Effects of
ethyl pyruvate on myocardial apoptosis and expression of Bcl-2 and
Bax proteins after ischemia-reperfusion in rats. J Huazhong Univ
Sci Technolog Med Sci. 28:281–283. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hu X, Cui B, Zhou X, et al: Ethyl pyruvate
reduces myocardial ischemia and reperfusion injury by inhibiting
high mobility group box 1 protein in rats. Mol Biol Rep.
39:227–231. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jahania MS, Sanchez JA, Narayan P, Lasley
RD and Mentzer RM Jr: Heart preservation for transplantation:
principles and strategies. Ann Thorac Surg. 68:1983–1987. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
DeBoer LW, Bekx PA, Han L and Steinke L:
Pyruvate enhances recovery of rat hearts after ischemia and
reperfusion by preventing free radical generation. Am J Physiol.
265:H1571–H1576. 1993.PubMed/NCBI
|
|
8
|
Manthorpe M, Cornefert-Jensen F, Hartikka
J, Felgner J, Rundell A, Margalith M and Dwarki V: Gene therapy by
intramuscular injection of plasmid DNA: studies on firefly
luciferase gene expression in mice. Hum Gene Ther. 4:419–431. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Stanley PE: Extraction of adenosine
triphosphate from microbial and somatic cells. Methods Enzymol.
133:14–22. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yagi K: A simple fluorometric assay for
lipoperoxide in blood plasma. Biochem Med. 15:212–216. 1976.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ochiai K, Zhang J, Gong G, Zhang Y, Liu J,
Ye Y, Wu X, Liu H, Murakami Y, Bache RJ, Ugurbil K and From AH:
Effects of augmented delivery of pyruvate on myocardial high-energy
phosphate metabolism at high workstate. Am J Physiol Heart Circ
Physiol. 281:H1823–H1832. 2001.PubMed/NCBI
|
|
12
|
Mallet RT: Pyruvate: metabolic protector
of cardiac performance. Proc Soc Exp Biol Med. 223:136–148. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Olivencia-Yurvati AH, Blair JL, Baig M and
Mallet RT: Pyruvate-enhanced cardioprotection during surgery with
cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 17:715–720.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fink MP: Ethyl pyruvate: a novel
anti-inflammatory agent. J Intern Med. 261:349–362. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mallet RT, Sun J, Knott EM, Sharma AB and
Olivencia-Yurvati AH: Metabolic cardioprotection by pyruvate:
recent progress. Exp Biol Med (Maywood). 230:435–443.
2005.PubMed/NCBI
|
|
16
|
Aneja R and Fink MP: Promising therapeutic
agents for sepsis. Trends Microbiol. 15:31–37. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cruz RJ Jr, Harada T, Sasatomi E and Fink
MP: Effects of ethyl pyruvate and other α-keto carboxylic acid
derivatives in a rat model of multivisceral ischemia and
reperfusion. J Surg Res. 165:151–157. 2011.
|
|
18
|
Wang Y, Li B, Li Z, Huang S, Wang J and
Sun R: Improvement of hypoxia-ischemia-induced white matter injury
in immature rat brain by ethyl pyruvate. Neurochem Res. 38:742–752.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kung CW, Lee YM, Cheng PY, Peng YJ and Yen
MH: Ethyl pyruvate reduces acute lung injury via regulation of iNOS
and HO-1 expression in endotoxemic rats. J Surg Res. 167:323–331.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Akkoc H, Kelle I, Tunik S, Bahceci S,
Sencar L, Ayaz E, Nergiz Y, Erdinc L and Erdinc M: Protective
effect of ethyl pyruvate on liver injury in streptozotocin-induced
diabetic rats. Acta Gastroenterol Belg. 75:336–341. 2012.PubMed/NCBI
|
|
21
|
Han Y, Englert JA, Yang R, Delude RL and
Fink MP: Ethyl pyruvate inhibits nuclear factor-kappaB-dependent
signaling by directly targeting p65. J Pharmacol Exp Ther.
312:1097–1105. 2005. View Article : Google Scholar
|
|
22
|
Uchiyama T, Delude RL and Fink MP:
Dose-dependent effects of ethyl pyruvate in mice subjected to
mesenteric ischemia and reperfusion. Intensive Care Med.
29:2050–2058. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Raedschelders K, Ansley DM and Chen DD:
The cellular and molecular origin of reactive oxygen species
generation during myocardial ischemia and reperfusion. Pharmacol
Ther. 133:230–255. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kao KK and Fink MP: The biochemical basis
for the anti-inflammatory and cytoprotective actions of ethyl
pyruvate and related compounds. Biochem Pharmacol. 80:151–159.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fink MP: Ethyl pyruvate. Curr Opin
Anaesthesiol. 21:160–167. 2008. View Article : Google Scholar
|
|
26
|
Sinha K, Das J, Pal PB and Sil PC:
Oxidative stress: the mitochondria-dependent and
mitochondria-independent pathways of apoptosis. Arch Toxicol.
87:1157–1180. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Handy DE and Loscalzo J: Redox regulation
of mitochondrial function. Antioxid Redox Signal. 16:1323–1367.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Frank A, Bonney M, Bonney S, Weitzel L,
Koeppen M and Eckle T: Myocardial ischemia reperfusion injury: from
basic science to clinical bedside. Semin Cardiothorac Vasc Anesth.
16:123–132. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dobsák P, Siegelova J, Wolf JE, Rochette
L, Eicher JC, Vasku J, Kuchtickova S and Horky M: Prevention of
apoptosis by deferoxamine during 4 hours of cold cardioplegia and
reperfusion: in vitro study of isolated working rat heart model.
Pathophysiology. 9:272002.PubMed/NCBI
|
|
30
|
Yue TL, Ma XL, Wang X, Romanic AM, Liu GL,
Louden C, Gu JL, Kumar S, Poste G, Ruffolo RR Jr and Feuerstein GZ:
Possible involvement of stress-activated protein kinase signaling
pathway and Fas receptor expression in prevention of
ischemia/reperfusion-induced cardiomyocyte apoptosis by carvedilol.
Circ Res. 82:166–74. 1998. View Article : Google Scholar
|
|
31
|
Martin BJ, Valdivia HH, Bünger R, Lasley
RD and Mentzer RM Jr: Pyruvate augments calcium transients and cell
shortening in rat ventricular myocytes. Am J Physiol. 274:H8–H17.
1998.PubMed/NCBI
|
